Kinetics of blood CD34 + cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use

Annals of Hematology

Volumn 91, Issue 7, 2012, Pages 1073-1079

  Jantunen, E ^a,b   Varmavuo, V ^b   Juutilainen, A ^a,b   Kuittinen, T ^b   Mahlamaki E ^c   Mantymaa P ^c   Nousiainen, T ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Cancer Center of Eastern Finland   (Finland)

Author keywords

Algorithm; Plerixafor; Poor mobilizers; Pre emptive; Stem cell mobilization

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CD34+ CELL; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CELL KINETICS; CELLS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEM CELL MOBILIZATION;

ADULT; AGED; ANTI-HIV AGENTS; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOPREVENTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROCYCLIC COMPOUNDS; HUMANS; KINETICS; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE;

EID: 84862760549     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1411-8     Document Type: Article

References (15)

1. W Bensinger JF DiPersio JM McCarty 2009 Improving stem cell mobilization strategies: future directions Bone Marrow Transplant 43 181 195 19139734 10.1038/bmt.2008.410 1:CAS:528:DC%2BD1MXhslSgtLg%3D
2. E Jantunen G Kvalheim 2010 Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies Eur J Haematol 85 463 471 20738393 10.1111/j.1600-0609.2010.01520.x
3. JF DiPersio I Micallef PJ Stiff BJ Bolwell RT Maziarz E Jacobsen, et al. 2009 Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma J Clin Oncol 27 4767 4773 19720922 10.1200/JCO.2008.20.7209 1:CAS:528:DC%2BD1MXhtlGgtbbI
4. JF DiPersio EA Stadtmauer A Nademanee IN Micallef PJ Stiff JL Kaufman, et al. 2009 Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Blood 113 5720 5726 19363221 1:CAS:528: DC%2BD1MXnsVSksL4%3D
5. MJ Dugan RT Maziarz WI Bensinger A Nademanee J Liesveld K Badel, et al. 2010 Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization Bone Marrow Transplant 45 39 47 19483760 10.1038/bmt.2009.119 1:CAS:528:DC%2BC3cXltlCjsg%3D%3D
6. A d'Addio A Curti N Worel K Douglas MR Motta S Rizzi, et al. 2011 The addition of plerixafor is safe and allow adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF Bone Marrow Transplant 46 456 463
7. E Jantunen T Kuittinen E Mahlamäki M Pyörälä P Mäntymaa T Nousiainen 2011 Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience Eur J Haematol 86 299 304 21198864 10.1111/j.1600-0609.2010.01573.x 1:CAS:528:DC%2BC3MXls1Crt7w%3D
8. I Pusic SY Jieng S Landua GL Uy MO Rettig AF Cashen, et al. 2008 Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation Biol Blood Marrow Transplant 14 1045 1056 18721768 10.1016/j.bbmt.2008.07.004 1:CAS:528:DC%2BD1cXhtFemurjI
9. P Wuchter D Ran T Bruckner T Schmitt M Witzens-Harig K Neben, et al. 2010 Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation Biol Blood Marrow Transplant 16 490 499 19925876 10.1016/j.bbmt.2009.11.012 1:CAS:528: DC%2BC3cXksl2gurs%3D
10. LJ Costa AN Miller ET Alexander KR Hogan M Shabbir C Schaub, et al. 2011 Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization Bone Marrow Transplant 46 64 69 20383210 10.1038/bmt.2010.78 1:STN:280: DC%2BC3M7gsValtg%3D%3D
11. E Jantunen 2011 Novel strategies for blood stem cell mobilization: special focus on plerixafor Expert Opin Biol Ther 11 1241 1248 21806478 10.1517/14712598.2011.601737 1:CAS:528:DC%2BC3MXpsFCqt7c%3D
12. R Seggewiss EC Buss D Herrmann H Goldschmidt AD Ho S Fruehauf 2003 Kinetics of peripheral blood stem cell mobilization following G-CSF supported chemotherapy Stem Cell 21 568 574 10.1634/stemcells.21-5-568 1:CAS:528:DC%2BD3sXnvFeis74%3D
13. GW Basak G Mikala Z Koristek O Jaksic S Basic-Kinda A Cegledi, et al. 2011 Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late Leuk Lymphoma 52 1711 1719 21663509 10.3109/10428194.2011. 578312 1:CAS:528:DC%2BC3MXhtVygt73E
14. Jantunen E, Lemoli R (2011) Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept. Transfusion 2011 Oct 7 (e-pub ahead of a print)
15. GW Basak E Urbanowska P Boguradzki T Torosian K Halaburda W Wiktor-Jedrzejczak 2010 Booster of plerixafor can be successfully used in addition to chemotherapy-based regimen to rescue stem cell mobilization failure Ann Transplant 15 61 67 21183878 1:CAS:528:DC%2BC3MXkvVaqur8%3D